(Q36326291)

13 August 2017

1 reference

title

Oncolytic potential of rodent parvoviruses for cancer therapy in humans: a brief review (English)

1 reference

13 August 2017

1 reference

Geletneky K

1

1 reference

13 August 2017

Herrero Y Calle M

series ordinal

2

1 reference

13 August 2017

Rommelaere J

series ordinal

3

1 reference

13 August 2017

Schlehofer JR

series ordinal

4

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Zoonoses and Public Health

13 August 2017

published in

1 reference

13 August 2017

volume

52

1 reference

13 August 2017

issue

7-8

1 reference

13 August 2017

page(s)

327-330

1 reference

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

MTH-68/H oncolytic viral treatment in human high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Intergeneric poliovirus recombinants for the treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Limitations to the expression of parvoviral nonstructural proteins may determine the extent of sensitization of EJ-ras-transformed rat cells to minute virus of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Genetically engineered HSV in the treatment of glioma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Antineoplasic activity of parvoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

Reovirus as an oncolytic agent against experimental human malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0450.2005.00877.X

10.1111/J.1439-0450.2005.00877.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference